economy
중도 성향
Eli Lilly is striking a $1.9 billion gene-editing deal to develop inherited kidney disease treatments
Quartz
조회 0
The agreement gives Lilly exclusive rights to Ascidian's RNA exon-editing technology, which repairs faulty genes without altering a patient's DNA ...
관련 뉴스
관련 뉴스 제보는 로그인 후 가능합니다.